全文获取类型
收费全文 | 123559篇 |
免费 | 46865篇 |
国内免费 | 256篇 |
专业分类
耳鼻咽喉 | 2101篇 |
儿科学 | 5343篇 |
妇产科学 | 1778篇 |
基础医学 | 22227篇 |
口腔科学 | 6564篇 |
临床医学 | 17817篇 |
内科学 | 33632篇 |
皮肤病学 | 8135篇 |
神经病学 | 18015篇 |
特种医学 | 3997篇 |
外科学 | 20014篇 |
综合类 | 336篇 |
一般理论 | 67篇 |
预防医学 | 7688篇 |
眼科学 | 2027篇 |
药学 | 9017篇 |
1篇 | |
中国医学 | 1075篇 |
肿瘤学 | 10846篇 |
出版年
2023年 | 350篇 |
2022年 | 689篇 |
2021年 | 2409篇 |
2020年 | 5708篇 |
2019年 | 11634篇 |
2018年 | 11160篇 |
2017年 | 12322篇 |
2016年 | 13155篇 |
2015年 | 13075篇 |
2014年 | 13446篇 |
2013年 | 14644篇 |
2012年 | 7863篇 |
2011年 | 7992篇 |
2010年 | 11152篇 |
2009年 | 7373篇 |
2008年 | 5336篇 |
2007年 | 4470篇 |
2006年 | 4150篇 |
2005年 | 3947篇 |
2004年 | 3679篇 |
2003年 | 3492篇 |
2002年 | 3353篇 |
2001年 | 1189篇 |
2000年 | 1036篇 |
1999年 | 736篇 |
1998年 | 601篇 |
1997年 | 489篇 |
1996年 | 435篇 |
1995年 | 371篇 |
1994年 | 330篇 |
1993年 | 321篇 |
1992年 | 256篇 |
1991年 | 241篇 |
1990年 | 222篇 |
1989年 | 233篇 |
1988年 | 202篇 |
1987年 | 183篇 |
1986年 | 185篇 |
1985年 | 222篇 |
1984年 | 196篇 |
1983年 | 170篇 |
1982年 | 203篇 |
1981年 | 170篇 |
1980年 | 144篇 |
1979年 | 114篇 |
1978年 | 125篇 |
1977年 | 133篇 |
1976年 | 97篇 |
1975年 | 110篇 |
1974年 | 82篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
991.
992.
993.
Functional expression of 4-1BB (CD137) in the inflammatory tissue in Crohn's disease 总被引:2,自引:0,他引:2
Maerten P Geboes K De Hertogh G Shen C Cadot P Bullens DM Van Assche G Penninckx F Rutgeerts P Ceuppens JL 《Clinical immunology (Orlando, Fla.)》2004,112(3):239-246
4-1BB ligand (L) expressed on antigen presenting cells (APC) interacts with 4-1BB, expressed on activated T cells and this interaction costimulates T cells to secrete cytokines and to proliferate. We investigated whether 4-1BB/4-1BBL interactions might be involved in the pathogenesis of Crohn's disease (CD). In immunohistochemistry, we found 4-1BB expression on lamina propria (LP) cells in inflamed and to a lesser extend in non-inflamed gut tissue from CD patients. mRNA levels for 4-1BB were also elevated in intestinal CD tissue. In contrast, only few 4-1BB-expressing cells were found in inflamed tissue from ulcerative colitis (UC) patients and almost no positive cells were found in control intestinal tissue. 4-1BB expression was better sustained on in vitro activated lamina propria T cells from CD patients compared to controls. Finally, agonistic anti-4-1BB antibody enhanced interferon-gamma (IFN-gamma) production and proliferation of lamina propria T cells from CD patients. Taken together, our data suggest that 4-1BB/4-1BBL interactions contribute to the persistence of gut inflammation in CD. 相似文献
994.
The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans 总被引:1,自引:0,他引:1
Dzhambazov B Holmdahl M Yamada H Lu S Vestberg M Holm B Johnell O Kihlberg J Holmdahl R 《European journal of immunology》2005,35(2):357-366
Type II collagen (CII) is a target for autoreactive T cells in both rheumatoid arthritis and the murine model collagen-induced arthritis. The determinant core of CII has been identified as CII260-270, and the alteration of this T cell epitope by posttranslational modifications is known to be critical for development of arthritis in mice. Using CII-specific T cell hybridomas we have now shown that the immunodominant T cell epitope in the normal (healthy) human and rat joint cartilage is O-glycosylated at the critical T cell receptor recognition position 264 with a mono- or di-saccharide attached to a hydroxylysine. In contrast, in the arthritic human and rat joint cartilage there are both glycosylated and non-glycosylated CII forms. Glycosylated CII from normal cartilage could not be recognized by T cells reactive to peptides having only lysine or hydroxylysine at position 264, showing that antigen-presenting cells could not degrade the O-linked carbohydrate. Thus, the variable forms of the glycosylated epitope are determined by the structures present in cartilage, and these vary during the disease course. We conclude that the chondrocyte determines the structures presented to the immune system and that these structures are different in normal versus arthritic states. 相似文献
995.
Quy N. Diep Thomas Bøhmer Jan I. Holme Ansgar Torvik Olav T. Storrøsten Christian W. Loennecken Per Monstad Egil Jellum 《Pharmacy World & Science》1993,15(5):225-229
Long-term treatment with pivampicillin and pivmecillinam for 6–24 months in five adults and one child reduced the total serum carnitine concentration to 3.7–14 mol/l (reference value: 25–66 mol/l). Muscle carnitine was reduced to 0.3–0.7mol/g wet weight (reference value: 3–5mol/g) in two cases. All patients had muscle symptoms with weakness, asthenia and pains. One showed signs of carnitine depletion in the liver with increased secretion of dicarboxylic acids (C6, C8, C10) in urine and limited ketone body formation during prolonged fasting. Serum carnitine increased slowly after cessation of therapy and reached normal concentrations after 6–12 months. All symptoms caused by carnitine depletion disappeared. This was achieved on a normal diet without carnitine supplementation. 相似文献
996.
Ann L. Meulemans Ludo F. Helsen Jan A. J. Schuurkes 《Naunyn-Schmiedeberg's archives of pharmacology》1993,347(2):225-230
Summary Vagal stimulation of the stomach induces a relaxation mediated via non-adrenergic, non-cholinergic (NANC) nerves. The neurotransmitter which is responsible for this relaxation is still unknown. To determine whether nitric oxide (NO) or a NO related substance mediates this relaxation, an intact guinea-pig stomach was mounted in an organ bath, with electrodes surrounding the vagal nerves.Electrical stimulation of the vagal nerves, in the presence of atropine, induced frequency dependent, tetrodotoxin-(TTX) sensitive relaxations of the stomach quantified as changes in volume. These relaxations were not affected by - or -adrenoceptor antagonists or guanethidine. Thus they were evoked by non-adrenergic, non-cholinergic (NANC) inhibitory nerves. The relaxant responses could be inhibited in a concentration-dependent manner by NG-nitro-Irarginine (IrNNA) a substance that inhibits the formation of nitric oxide (NO). Addition of L-arginine, the substrate for NO-synthase, reversed the L-NNA-induced-inhibition of the relaxation.Addition of nitroglycerin (a NO-donor) to a nonstimulated stomach mimicked the relaxations observed after vagal stimulation in a concentration dependent manner. These relaxations were insensitive to TTX. Relaxation of the stomach by vagal stimulation was prevented by an inhibitor of soluble guanylate cyclase, methylene blue, further supporting our conclusions.These data indicate that NO or a substance releasing NO plays an important role in NANC-neurotransmission after vagal stimulation of the guinea-pig stomach.Correspondence to A. L. Meulemans at the above address 相似文献
997.
Ann L. Meulemans Ludo F. Helsen Jan A. J. Schuurkes 《Naunyn-Schmiedeberg's archives of pharmacology》1993,348(4):424-430
Summary In a previous study we showed that the relaxations induced after vagal stimulation of the guinea-pig stomach are mediated via nitric oxide (NO) or a NO-related substance. Intra-arterial injection (i.a.) of 5-hydroxytryptamine (5-HT) also induced relaxations in the guinea-pig stomach. Since it has been shown that in the guinea-pig colon 5-HT-induced relaxations are mediated via NO the aim of this study was to establish whether NO is involved in the 5-HT-induced relaxations in the guinea-pig stomach. Intra-arterial injection of 5-HT induced dose-dependent relaxations of the stomach. Since atropine and - and -adrenoceptor blocking agents did not influence the relaxation and since tetrodotoxin (TTX) blocked the relaxations, this effect is mediated via NANC-neurons. Administration of a NO-synthase-inhibitor NG-nitro-l-arginine (L-NNA) concentration-dependently reduced the 5-HT-induced relaxations. Haemoglobin (a NO-scavanger) did not affect the relaxations to 5-HT, while addition of methylene blue, an inhibitor of soluble guanylate cyclase, reduced the relaxations by 50%. Addition of an opioid receptor agonist (loperamide), a 5-HT1 antagonist (methiothepin or metergoline) or a 5-HT4 receptor agonist (cisapride) or-antagonist (tropisetron in micromolar concentrations) inhibited the 5-HT-induced relaxations. Neither the 5-HT4 receptor agonist renzapride, nor the novel 5-HT4 receptor antagonist SDZ 205-557, affected the relaxations to 5-HT. These data indicate that 5-HT-induced relaxations of the guinea-pig stomach are mediated via NANC-inhibitory nerves on which inhibitory opioid-receptors are present. The use of selective agonists and antagonists indicates that 5-HT does not act via 5-HT2, 5-HT3 or 5-HT4 receptors. 5-HT may act via 5-HT1 receptors but the subtype involved, if any, has not yet been identified. The inhibitory neurotransmitter which is involved is NO or a NO-related substance.
Correspondence to A. L. Meulemans at the above address 相似文献
998.
Ricour C Gorski AM Goulet O de Potter S Corriol O Postaire M Nihoul-Fekete C Jan D Revillon Y Lortat-Jacob S Pellerin D 《Clinical nutrition (Edinburgh, Scotland)》1990,9(2):65-71
It is essential that children on prolonged parenteral nutrition for anatomical or functional loss of small bowel should enjoy a quality of life which is as normal as possible. Their return home is a major factor in this. Over the past 8 years, 112 children were able to remain at home on cyclic parenteral nutrition. Forty-nine of them are no longer on home parenteral nutrition (HPN), 45 are still on HPN, and 18 have died. Growth and quality of life were good in most cases. Most of the complications were from infection, 1 septicaemia per 594 days on HPN. In the light of these results, HPN seems to be the best option for children requiring prolonged parenteral nutrition, although it can only be considered within the framework of a specialized centre, which ensures patient follow-up, and provides the logistical support required for this high-technology treatment. 相似文献
999.
Andrew I. Jun Wyman T. McGuirt Raul Hinojosa Glenn E. Green Nathan Fischel‐Ghodsian Richard J. H. Smith 《The Laryngoscope》2000,110(2):269-269
Objective: Mutations in GJB2, a gene that encodes a gap junction protein, Connexin 26 (Cx26), are responsible for approximately one third of sporadic severe‐to‐profound or profound congenital deafness and half of severe‐to‐profound or profound autosomal recessive nonsyndromic hearing loss (ARNSHL). Mouse mutants homozygous for knockouts of this gene are nonviable, precluding histopathologic studies of the associated inner ear pathology in this animal model. Therefore, we studied archival temporal bone sections to identify temporal bone donors with Cx26‐related deafness. Study Design: Temporal bone donors with a history of congenital severe‐to‐profound or profound deafness were identified in the registry of the Temporal Bone Library at the University of Iowa. Histological findings were interpreted in a blinded fashion. DNA extracted from two celloidin‐embedded mid‐modiolar sections from each temporal bone was screened for the 35delG Cx26 mutation. The entire coding region of Cx26 was screened for other deafness‐causing mutations if the 35delG mutation was detected. Results: Of five temporal bone donors with congenital severe‐to‐profound deafness, one donor was found to have Cx26‐related deafness. This individual was a Cx26 compound heterozygote, carrying the 35delG mutation and a noncomplementary Cx26 missense mutation on the opposing allele. Microscopic evaluation of this temporal bone showed no neural degeneration, a good population of spiral ganglion cells, near‐total degeneration of hair cells in the organ of Corti, a detached and rolled‐up tectorial membrane, agenesis of the stria vascularis, and a large cyst in the scala media in the region of the stria vascularis. Conclusion: This study is the first to report the temporal bone histopathology associated with Cx26‐related deafness. Preservation of neurons in the spiral ganglion suggests that long‐term successful habilitation with cochlear implants may be possible in persons with severe‐to‐profound or profound Cx26‐related deafness. 相似文献
1000.
Jean‐Baptiste Lecanu Guy Monceaux Sophie Pri Bruno Angelard Jean Lacau St. Guily 《The Laryngoscope》2000,110(3):412-416
Objective To evaluate the possibility of preservation of the larynx after neoadjuvant chemotherapy by performing a conservative surgery instead of total laryngectomy initially planned, in patients with previously untreated laryngeal and piriform sinus squamous cell carcinoma (SCC). Study Design Retrospective study. Methods A total of 115 patients treated at Tenon Hospital with induction chemotherapy from 1985 to 1995, all with initial indication of radical surgery, were available for the study. The clinical tumor response was evaluated after three cycles of chemotherapy. According to this response, to preserve laryngeal functions, some patients had a modification of the treatment initially planned: radiation therapy essentially for complete responders, and conservative surgery for some partial responders. Results Of 69 patients with laryngeal cancer, 14 were treated by partial laryngectomy and 19 by radiation therapy; of 46 patients with piriform sinus cancer, 8 were treated by partial surgery and 12 by radiation therapy; the other patients were treated as was initially planned (total laryngectomy with partial pharyngectomy). Overall survival rates, estimated by the Kaplan‐Meier method, were not statistically different between the three treatment groups. The laryngeal functions were preserved in 54% of the patients who were alive at 3 years. Conclusion This report is a retrospective study, but these results suggest the possibility of using conservative surgery, instead of initially planned total laryngectomy, for good responders to induction chemotherapy with a small residual tumor. 相似文献